Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Photo Release -- Amyris Ships First Truckload of Biofene From Its New Plant in Brazil



Photo Release -- Amyris Ships First Truckload of Biofene From Its New Plant in
Brazil

Amyris's Renewable Farnesene, Produced From Sugarcane, Will be Used for a
Variety of Specialty Chemical and Fuel Applications

EMERYVILLE, Calif., Feb. 1, 2013 (GLOBE NEWSWIRE) -- Amyris, Inc.
(Nasdaq:AMRS), a leading renewable chemicals and fuels company, announced
today the first commercial shipment from its new plant in Brazil. Amyris's
first purpose-built industrial fermentation facility produces Biofene^®,
Amyris's brand of renewable farnesene, to be used in a range of specialty
chemical and fuel applications.

Amyris Ships First Truckload of Biofene
From Its New Plant i
 Amyris Ships First Truckload of Biofene
 From Its New Plant in Brazil

A photo accompanying this release is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=16954

"This initial shipment marks the successful completion of our start-up
activities. We have operated multiple tanks without contamination or surprises
through several production runs during the first month of operation," said
John Melo, President and CEO of Amyris.

"We are now focused on ramping up Biofene production and delivering product to
our customers, from renewable diesel for bus fleets in Brazil to squalane
emollient globally and soon a range of specialty chemical applications," Melo
concluded.

Amyris's Biofene plant in Brotas, in the state of São Paulo, Brazil, sources
its sugarcane feedstock locally from the Paraíso mill. Prior to the start-up
of this facility, Amyris relied solely on contract manufacturing for
commercial production.

As previously announced, Amyris will report financial results for the fourth
quarter 2012 and provide a business update on February 19, 2013, after the
close of market.

About Amyris, Inc.

Amyris is an integrated renewable products company focused on providing
sustainable alternatives to a broad range of petroleum-sourced products.
Amyris uses its industrial synthetic biology platform to convert plant sugars
into a variety of hydrocarbon molecules—flexible building blocks that can be
used in a wide range of products. Amyris's initial portfolio of commercial
products is based on Biofene®, Amyris's brand of renewable farnesene, a
long-chain hydrocarbon. Amyris is commercializing these products both as No
Compromise® renewable ingredients in cosmetics, flavors and fragrances,
polymers, lubricants and consumer products, and also as No Compromise
renewable diesel and jet fuel. Amyris Brasil Ltda., a subsidiary of Amyris,
oversees the establishment and expansion of Amyris's production in Brazil.
More information about Amyris is available at www.amyris.com.  

The Amyris, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=12462

Forward-Looking Statements

This release contains forward-looking statements, and any statements other
than statements of historical facts could be deemed to be forward-looking
statements. These forward-looking statements include, among other things,
statements regarding future events (such as ramping up production at a
manufacturing facility and delivering products to customers) that involve
risks and uncertainties. These statements are based on management's current
expectations and actual results and future events may differ materially due to
risks and uncertainties, including those associated with any delays or
failures in development, production or commercialization of products,
liquidity and ability to fund capital expenditures, Amyris's reliance on third
parties to achieve its goals, and other risks detailed in the "Risk Factors"
section of Amyris's quarterly report on Form 10-Q filed on November 9, 2012.
Amyris disclaims any obligation to update information contained in these
forward-looking statements whether as a result of new information, future
events, or otherwise.

Amyris, Biofene and No Compromise are trademarks or registered trademarks of
Amyris, Inc. 

The photo is also available at Newscom, www.newscom.com, and via AP
PhotoExpress.

CONTACT: Media and Investor Relations
         Joel Velasco
         +1 (510) 597-5577
         info@amyris.com

company logo
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement